Table 1 Baseline characteristics of patients with diffuse large B-cell lymphoma in the training set.

From: Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2

Characteristics

Total n = 221 (%)

BCL2 AQUA score

MYC AQUA score

Low n = 135 (%)

High n = 86 (%)

p value

n = 166 (%)

n = 55 (%)

p value

Age > 60 years

98 (44.3)

58 (43.0)

40 (46.5)

0.605

62 (37.3)

36 (65.5)

0.0003

Sex, male

126 (57.0)

77 (57.0)

49 (57.0)

0.9930

97 (58.4)

29 (52.7)

0.4588

LDH > normal

101 (45.7)

59 (43.7)

42 (48.8)

0.455

67 (40.4)

34 (61.8)

0.0056

B symptoms+

58/219 (26.5)

29/133 (21.8)

29 (33.7)

0.0510

42/165 (25.5)

16/54 (29.6)

0.5462

 

NA (2)

NA (2)

  

NA (1)

NA (1)

 

Hb < normal

109 (49.3)

61 (45.2)

48 (55.8)

0.1233

79 (47.6)

30 (54.5)

0.3712

Stage 3–4

126 (57.0)

74 (54.8)

52 (60.5)

0.408

93 (56.0)

33 (60.0)

0.6057

IPI 3–5

81 (36.7)

44 (32.6)

37 (43.0)

0.1167

56 (33.7)

25 (45.5)

0.1180

BM involvement

45/220 (20.5)

28 (20.7)

17/85 (20.0)

0.895

34 (20.5)

11/54 (20.4)

0.9859

 

NA (1)

 

NA (1)

  

NA (1)

 

CR

195 (88.2)

126 (93.3)

69 (82.2)

0.003

154 (92.8)

41 (74.5)

0.0003

2-years EFS rate (%)

70.34

80.93

54.04

 

75.36

55.02

 

Non-GCB type

142/207 (68.6)

78/126 (61.9)

64/81 (79.0)

0.01

106/156 (67.9)

36/51 (70.6)

0.7244

 

NA (14)

NA (9)

NA (5)

 

NA (10)

NA (4)

 
  1. LDH lactate dehydrogenase, IPI International Prognostic Index, CR complete response, EFS event-free survival, AQUA automated quantitative analysis, NA not available.